vs

Side-by-side financial comparison of MERCURY SYSTEMS INC (MRCY) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

MERCURY SYSTEMS INC is the larger business by last-quarter revenue ($232.9M vs $127.1M, roughly 1.8× Zai Lab Ltd). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs 4.4%). MERCURY SYSTEMS INC produced more free cash flow last quarter ($45.7M vs $-26.7M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 5.7%).

Mercury Systems, Inc. is a technology company serving the aerospace and defense industry. It designs, develops and manufactures open architecture computer hardware and software products, including secure embedded processing modules and subsystems, avionics mission computers and displays, rugged secure computer servers, and trusted microelectronics components, modules and subsystems.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

MRCY vs ZLAB — Head-to-Head

Bigger by revenue
MRCY
MRCY
1.8× larger
MRCY
$232.9M
$127.1M
ZLAB
Growing faster (revenue YoY)
ZLAB
ZLAB
+12.7% gap
ZLAB
17.1%
4.4%
MRCY
More free cash flow
MRCY
MRCY
$72.4M more FCF
MRCY
$45.7M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
5.7%
MRCY

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
MRCY
MRCY
ZLAB
ZLAB
Revenue
$232.9M
$127.1M
Net Profit
$-15.1M
Gross Margin
26.0%
51.0%
Operating Margin
-4.6%
-54.6%
Net Margin
-6.5%
Revenue YoY
4.4%
17.1%
Net Profit YoY
14.1%
EPS (diluted)
$-0.26
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRCY
MRCY
ZLAB
ZLAB
Q4 25
$232.9M
$127.1M
Q3 25
$225.2M
$115.4M
Q2 25
$273.1M
$109.1M
Q1 25
$211.4M
$105.7M
Q4 24
$223.1M
$108.5M
Q3 24
$204.4M
$101.8M
Q2 24
$248.6M
$100.1M
Q1 24
$208.3M
$87.1M
Net Profit
MRCY
MRCY
ZLAB
ZLAB
Q4 25
$-15.1M
Q3 25
$-12.5M
$-36.0M
Q2 25
$16.4M
$-40.7M
Q1 25
$-19.2M
$-48.4M
Q4 24
$-17.6M
Q3 24
$-17.5M
$-41.7M
Q2 24
$-10.8M
$-80.3M
Q1 24
$-44.6M
$-53.5M
Gross Margin
MRCY
MRCY
ZLAB
ZLAB
Q4 25
26.0%
51.0%
Q3 25
27.9%
59.5%
Q2 25
31.0%
60.6%
Q1 25
27.0%
63.6%
Q4 24
27.3%
61.5%
Q3 24
25.3%
64.1%
Q2 24
29.5%
64.9%
Q1 24
19.5%
61.4%
Operating Margin
MRCY
MRCY
ZLAB
ZLAB
Q4 25
-4.6%
-54.6%
Q3 25
-3.8%
-42.3%
Q2 25
8.6%
-50.3%
Q1 25
-8.2%
-53.3%
Q4 24
-5.6%
-62.6%
Q3 24
-6.6%
-66.6%
Q2 24
-3.2%
-76.0%
Q1 24
-21.9%
-80.7%
Net Margin
MRCY
MRCY
ZLAB
ZLAB
Q4 25
-6.5%
Q3 25
-5.6%
-31.2%
Q2 25
6.0%
-37.3%
Q1 25
-9.1%
-45.8%
Q4 24
-7.9%
Q3 24
-8.6%
-40.9%
Q2 24
-4.3%
-80.2%
Q1 24
-21.4%
-61.4%
EPS (diluted)
MRCY
MRCY
ZLAB
ZLAB
Q4 25
$-0.26
$-0.05
Q3 25
$-0.21
$-0.03
Q2 25
$0.28
$-0.04
Q1 25
$-0.33
$-0.04
Q4 24
$-0.30
$-0.09
Q3 24
$-0.30
$-0.04
Q2 24
$-0.18
$-0.08
Q1 24
$-0.77
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRCY
MRCY
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$335.0M
$689.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.5B
$715.5M
Total Assets
$2.5B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRCY
MRCY
ZLAB
ZLAB
Q4 25
$335.0M
$689.6M
Q3 25
$304.7M
$717.2M
Q2 25
$309.1M
$732.2M
Q1 25
$269.8M
$757.3M
Q4 24
$242.6M
$779.7M
Q3 24
$158.1M
$616.1M
Q2 24
$180.5M
$630.0M
Q1 24
$142.6M
$650.8M
Stockholders' Equity
MRCY
MRCY
ZLAB
ZLAB
Q4 25
$1.5B
$715.5M
Q3 25
$1.5B
$759.9M
Q2 25
$1.5B
$791.7M
Q1 25
$1.5B
$810.8M
Q4 24
$1.5B
$840.9M
Q3 24
$1.5B
$667.7M
Q2 24
$1.5B
$704.2M
Q1 24
$1.5B
$762.2M
Total Assets
MRCY
MRCY
ZLAB
ZLAB
Q4 25
$2.5B
$1.2B
Q3 25
$2.5B
$1.2B
Q2 25
$2.4B
$1.2B
Q1 25
$2.4B
$1.2B
Q4 24
$2.4B
$1.2B
Q3 24
$2.4B
$985.3M
Q2 24
$2.4B
$987.4M
Q1 24
$2.4B
$988.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRCY
MRCY
ZLAB
ZLAB
Operating Cash FlowLast quarter
$51.6M
$-26.0M
Free Cash FlowOCF − Capex
$45.7M
$-26.7M
FCF MarginFCF / Revenue
19.6%
-21.0%
Capex IntensityCapex / Revenue
2.5%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$99.4M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRCY
MRCY
ZLAB
ZLAB
Q4 25
$51.6M
$-26.0M
Q3 25
$2.2M
$-32.0M
Q2 25
$38.1M
$-31.0M
Q1 25
$30.0M
$-61.7M
Q4 24
$85.5M
$-55.8M
Q3 24
$-14.7M
$-26.8M
Q2 24
$71.8M
$-42.2M
Q1 24
$-17.8M
$-90.1M
Free Cash Flow
MRCY
MRCY
ZLAB
ZLAB
Q4 25
$45.7M
$-26.7M
Q3 25
$-4.4M
$-35.0M
Q2 25
$34.0M
$-33.9M
Q1 25
$24.1M
$-63.2M
Q4 24
$81.9M
$-58.4M
Q3 24
$-20.9M
$-28.2M
Q2 24
$61.4M
$-42.9M
Q1 24
$-25.7M
$-91.1M
FCF Margin
MRCY
MRCY
ZLAB
ZLAB
Q4 25
19.6%
-21.0%
Q3 25
-1.9%
-30.4%
Q2 25
12.4%
-31.1%
Q1 25
11.4%
-59.9%
Q4 24
36.7%
-53.8%
Q3 24
-10.2%
-27.7%
Q2 24
24.7%
-42.9%
Q1 24
-12.4%
-104.5%
Capex Intensity
MRCY
MRCY
ZLAB
ZLAB
Q4 25
2.5%
0.5%
Q3 25
2.9%
2.6%
Q2 25
1.5%
2.6%
Q1 25
2.8%
1.5%
Q4 24
1.6%
2.4%
Q3 24
3.1%
1.3%
Q2 24
4.2%
0.7%
Q1 24
3.8%
1.1%
Cash Conversion
MRCY
MRCY
ZLAB
ZLAB
Q4 25
Q3 25
Q2 25
2.33×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRCY
MRCY

Airborne$84.2M36%
Components$48.7M21%
Other End Applications$36.8M16%
Electronic Warfare$27.5M12%
Other Sensor And Effector Applications$23.9M10%
Space$11.9M5%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons